JMI LABS IS NOW PART OF LEARN MORE

Susceptibility of Ceftolozane-Tazobactam against Isolates Collected from Intensive Care Unit Patients in US Hospitals from 2014-2016. Lead author: M Pfaller, presented at ASM Microbe 2017, June 1-5, New Orleans, Louisiana, USA
# Friday-76

View publication